Although clinical studies have shown that increased levels of TF+EVs in principle correlate with venous thrombosis in patients with cancer (Geddings and Mackman 2013; Khorana et al. 2008), these correlations are not uniformly found over all cancer types (Thaler et al. 2012). This evidence concerns the gene TF and cancer.